Locations:
SearchAdvertisement
Consider each patient's unique disease progression and treatment goals when choosing a strategy
New papers review the data and provide guidance on antiobesity medications and other options
Patient loses 148 pounds in 18 months, reduces BMI to 26
Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A weight-management program plus anti-obesity medication performs well
Cleveland Clinic study finds that durable weight loss is key to health benefits
Comprehensive approach can make a transformative impact
More report a clinically meaningful change in function at 90 days compared to patients with lower BMI
Positive emotions, low impulsivity appear to safeguard against weight gain, other comorbidities
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Advertisement
Advertisement